These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 26368542)

  • 1. Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy.
    Chong GO; Jeong SY; Park SH; Lee YH; Lee SW; Hong DG; Kim JC; Lee YS; Cho YL
    PLoS One; 2015; 10(9):e0137743. PubMed ID: 26368542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent Chemoradiotherapy.
    Son SH; Jeong SY; Chong GO; Lee YH; Park SH; Lee CH; Hong CM; Jeong JH; Lee SW; Ahn BC; Lee J
    Clin Nucl Med; 2018 Sep; 43(9):e296-e303. PubMed ID: 30036243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
    Hong JH; Min KJ; Lee JK; So KA; Jung US; Kim S; Eo JS
    Medicine (Baltimore); 2016 Mar; 95(9):e2992. PubMed ID: 26945420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of 18F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy.
    Onal C; Guler OC; Reyhan M; Yapar AF
    Gynecol Oncol; 2015 Apr; 137(1):40-6. PubMed ID: 25641567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the prognostic value of F-18 FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Dag Z; Yilmaz B; Dogan AK; Aksan DU; Ozkurt H; Kızılkaya HO; Arslan D
    Brachytherapy; 2019; 18(2):154-162. PubMed ID: 30594422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (
    Scher N; Castelli J; Depeursinge A; Bourhis J; Prior JO; Herrera FG; Ozsahin M
    Cancer Radiother; 2018 May; 22(3):229-235. PubMed ID: 29650390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node standardized uptake values at pre-treatment
    Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
    Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma.
    Calles-Sastre L; Mucientes-Rasilla J; San-Frutos Llorente LM; Royuela A; Garcia-Espantaleón Navas M; Herrero Gámiz S; Pérez-Medina T
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):17-21. PubMed ID: 30366731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
    Herrera FG; Breuneval T; Prior JO; Bourhis J; Ozsahin M
    Radiat Oncol; 2016 Mar; 11():43. PubMed ID: 26984385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of FDG PET metabolic tumour volume versus ADC histogram: prognostic value of tumour treatment response and survival in patients with locally advanced uterine cervical cancer.
    Ueno Y; Lisbona R; Tamada T; Alaref A; Sugimura K; Reinhold C
    Br J Radiol; 2017 Jul; 90(1075):20170035. PubMed ID: 28508679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer.
    Yilmaz B; Dağ S; Ergul N; Çermik TF
    Nucl Med Commun; 2019 Mar; 40(3):219-227. PubMed ID: 30585896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography.
    Yoo J; Choi JY; Moon SH; Bae DS; Park SB; Choe YS; Lee KH; Kim BT
    Int J Gynecol Cancer; 2012 Sep; 22(7):1226-33. PubMed ID: 22810970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of qualitative and quantitative ¹⁸F-FDG PET-CT parameters for predicting survival in recurrent carcinoma of the cervix.
    Maharjan S; Sharma P; Patel CD; Sharma DN; Dhull VS; Jain SK; Thulkar S; Malhotra A; Kumar R
    Nucl Med Commun; 2013 Aug; 34(8):741-8. PubMed ID: 23676840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer.
    De Cuypere M; Lovinfosse P; Gennigens C; Hermesse J; Rovira R; Duch J; Goffin F; Hustinx R; Kridelka F
    Int J Gynecol Cancer; 2020 Nov; 30(11):1705-1712. PubMed ID: 33033165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment metabolic tumour volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy.
    Guler OC; Torun N; Yildirim BA; Onal C
    Br J Radiol; 2018 Apr; 91(1084):20170552. PubMed ID: 29293366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer.
    Hong JH; Jung US; Min KJ; Lee JK; Kim S; Eo JS
    Nucl Med Commun; 2016 Aug; 37(8):843-8. PubMed ID: 27058362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
    Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC
    Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of the Metabolic Parameters of
    Wang D; Liu X; Wang W; Huo L; Pan Q; Ren X; Zhang F; Hu K
    Front Oncol; 2021; 11():698744. PubMed ID: 34490094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
    Cima S; Perrone AM; Castellucci P; Macchia G; Buwenge M; Cammelli S; Cilla S; Ferioli M; Ferrandina G; Galuppi A; Salizzoni E; Rubino D; Fanti S; De Iaco P; Morganti AG
    Int J Gynecol Cancer; 2018 Mar; 28(3):575-580. PubMed ID: 29372911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?
    Voglimacci M; Gabiache E; Lusque A; Ferron G; Ducassou A; Querleu D; Motton S; Chantalat E; Courbon F; Martinez A
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1551-1559. PubMed ID: 30729273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.